J&J may have to compensate for faulty hip implants

The reason it has taken so long to arrive at this decision is because there is currently no provision to compensate patients for drugs and devices that are already approved in the market, said officials.

from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2BRzYLo
via IFTTT